Meet the Team

We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced management team, renowned scientists, industry leading investors and expert advisors, to form a collaborative ecosystem, united through the common goal of advancing the science of precision health.


Kevin Hrusovsky

Chairman and Chief Executive Officer


Masoud Toloue, PhD

President of Quanterix and Diagnostics


William Geist

Chief Operating Officer


Michael Doyle

Chief Financial Officer


Mark Roskey, PhD

Senior Vice President, Strategic Partnerships


David Duffy, PhD

Vice President, Research and Chief Technology Officer


Denise Chittick

Chief Human Resources Officer


Dawn R. Mattoon, PhD

Senior Vice President, Clinical Diagnostics


Richard Haigh, PhD

Senior Vice President, Research Products


John Fry, JD

General Counsel and Corporate Secretary


Brian Keane, JD

Senior Vice President and Senior Legal Counsel


Gerrit Smith

Senior Vice President of Operations


Kristine Klinger

Vice President, Enterprise Program Management Office


Kevin Hrusovsky

Chairman and Chief Executive Officer


Martin Madaus, PhD

Chief Operations Officer, Sherlock Biosciences, Inc.


Keith L. Crandell

Co-Founder & Managing Director, ARCH Venture Partners


David Walt, PhD

Senior Investigator, Brigham and Women’s Hospital, Department of Pathology, Core Faculty Member-Wyss Institute, Harvard Medical School at Harvard University


Paul Meister

Co-founder and Chief Executive Officer, Liberty Lane Partners, LLC


Marijn Dekkers

Chairman of Novalis LifeSciences


Sarah Hlavinka

Senior Vice President and General Counsel, Itron


Laurie Olson

Former Executive Vice President of Strategy and Commercial Operations at Pfizer, Inc.

Ready to take your biomarker research to the next level?

request a quote